HI Hope

Most Recent Articles

Guidelines for Managing HI in School

Published on

Both medical management and neurodevelopmental conditions may require accommodations for your child with hyperinsulinism at school.

Q&A with Pediatric Endocrinologist Julia Crowley, MD

Published on


New pediatric endocrinologist Julia Crowley, MD, will see children in CHOP’s Congenital Hyperinsulinism Center. Meet her in this Q&A. [short teaser] Meet Julia Crowley, MD, will see children in CHOP’s Congenital Hyperinsulinism Center.

Two Focal Lesions: Extra Rare Cases Not so Rare at CHOP

Published on

The Congenital Hyperinsulinism Center at Children’s Hospital of Philadelphia, with a high volume of approximately 80 congenital hyperinsulinism (HI) cases a year, sees a large share of unusual cases.

Neurodevelopmental Outcomes in HI

Published on

Unrecognized or inadequately treated hyperinsulinism (HI) poses a high risk of adverse neurodevelopmental outcomes due to the combined insult of hypoglycemia and lack of alternate brain fuels.

When Hyperinsulinism is a Family Affair

Published on

Three Generations Under CHOP’s Care for HI - Rian

Inactivating mutations in the beta cell KATP channels are the most common cause of congenital hyperinsulinism (HI), accounting for approximately 60% of all cases with known genotype. The beta cell KATP channels play a very important role in the regulation of insulin secretion by coupling the metabolic state of the cell to membrane potential.

Radiology: Key Member of the HI Team

Published on

For the children with focal hyperinsulinism, the radiologist’s interpretation of a 18F-DOPA PET/CT scan guides the surgeon, leading to a cure in 97% of cases.